Are Patients Being Referred to Heart Failure Specialists Too Late?

• by

• September 25, 2026

Digoxin misses heart failure endpoint

Researchers observed fewer worsening heart failure events, but the trial did not establish a statistically significant benefit.

• by Kerri Miller

• October 29, 2026

• 5 min

Mortality score may refine heart allocation

A laboratory- and device-based model outperformed the current 6-status system in predicting short-term mortality among heart transplant candidates.

• by Andrea Surnit

• October 14, 2026

• 5 min

Circulating Dipeptidyl Peptidase 3 levels, an Antagonist of Angiotensin-(1–7), in Acute Heart Failure: Insights from the PUSH-AHF trial

• by Stijn Legtenberg, Karine Santos, Iris E. Beldhuis, Oliver Hartmann, Lara E.E.C. Zonneveld, Peter van der Meer, Jan A. Krikken, Wybe Nieuwland, Dirk J. van Veldhuisen, Adriaan A. Voors, Kevin Damman, Jozine M. ter Maaten

• September 4, 2026